Cameron, J. Dev. Biol. Stand. 24:155-65 (see abstract), 1974.* |
Bosy et al Lancet, 339:8792:507-510, 1992.* |
Dagan et al. ASM Mtg. 1996 p. 154 Abstract# G59.* |
Cherry. Vaccine 10/14:1033-1038, 1992.* |
Goldenthal. Anno N.Y. Acad. Sci 754:xi-xv, 1995.* |
Gustafsson et al. N. Eng. J. Med. 334:349-55, 1996.* |
Edwards et al. Pediatr. Infect. Dis. J. 13/5:345-47, 1994.* |
Dagan et al, Pediatr. Infect. Dis. J. 16/12:1113-1121, 1997.* |
Edwards et al Pediatr Infect. Dis. J. 16/4:S97-S102, 1997.* |
Parkman et al. Recent Advances in Immunization ed. Halsey et al pp 65-80, 1983.* |
Schmit et al ICAAG Mtg. 1997 Abstract # G-92.* |
David et al, ICAAG Mtg 1991 Abstract # 60, 1991.* |
Van Wezel, et al, Reviews of Infectious Dis. 6/Suppl 2:S335-S340, 1984.* |
Halperin et al, Ann. NY Acad. Sci. 754:89-96, 1995.* |
Baker et al, J Pediatr, 121:523-27, 1992.* |
Granoff, Pediatr Infect Dis J., 1996, 15:1069-1070. |
Gold, Ronald, et al; Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age—Pediatr. Infect. Dis. J. 1994: 13: 348-55. |
Plotkin, S.A., and Orenstein, W.A.,—Vaccines—Third Edition—1999. |
Insel, R.A.—Potential Alterations in Immunogenicity by Combining or Simultaneously Administering Vaccine Components, pp. 35-47. |
Frey, S., et al—Interference of Antibody Production to Hepatitis B Surface Antigen in a Combination Hepatitis A/Hepatitis B Vaccine—Journal of Inf. Dis.—1999: 180: 2018-22. |
Ambfrosch, F. et al—Combined Vaccination Against Yellow Fever and Typhoid Fever: a comparative trial; Vaccine 1994 vol. 12, No. 7; pp. 625-628. |
Fattom, A. et al—Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines—Vaccine 17 (1999) 126-133. |